Regionally advanced (stage III) vs. metastatic (stage IV) disease, and what each one means
Bring a printable list of questions to your appointment, or share this page with someone who needs it.
Most melanomas are found early, removed with surgery, and never come back. So it can be jarring to hear a doctor describe a melanoma as "advanced." The word sounds final, but in melanoma care it is simply a category — a shorthand for disease that has moved beyond the original spot on the skin and now needs more than an operation.
"Advanced melanoma" is not a single stage number. It is an umbrella label that covers two different situations: melanoma that has spread to nearby (regional) lymph nodes or the skin around the primary tumor, and melanoma that has spread to distant parts of the body. Knowing which one applies to you shapes the entire treatment conversation.
This page explains what each term means, the smaller labels you may hear inside them, and why the "advanced" label moves treatment toward medication that works throughout the body. For how doctors actually pin down the stage, see how advanced melanoma is staged and worked up. For a walk through every stage from 0 to IV, see what your melanoma stage means.
When oncologists and treatment guidelines say "advanced melanoma," they are grouping together two distinct problems that are managed with an overlapping set of medications:
The melanoma has spread to nearby lymph nodes, or has formed deposits in the skin and lymphatic channels between the original tumor and those nodes (satellite and in-transit metastases). It has not reached distant organs. Many stage III melanomas can still be removed with surgery, and treatment increasingly includes medication given before or after that surgery. This accounts for most advanced melanoma.
The melanoma has traveled beyond the regional lymph nodes to distant sites — most often distant skin and lymph nodes, the lungs, the liver, bone, or the brain. It is treated primarily with systemic therapy. When distant spread is limited to one or a few spots (oligometastatic disease), surgery or focused radiation may still play a role alongside medication.
Stage III means the melanoma has reached the regional lymph nodes or the tissue on the way to them, without any sign of distant spread. Within stage III, a few distinctions change the outlook and the plan:
Most people with stage III melanoma have surgery to remove the involved nodes and the primary site, followed by a discussion of adjuvant (after-surgery) medication to lower the chance of recurrence.
Stage IV means melanoma has been found at a distant site. To describe where, doctors use "M" categories from the AJCC staging system:
Each M category also carries a "(0)" or "(1)" for a normal or elevated blood level of LDH (lactate dehydrogenase), an enzyme that tends to rise when there is more melanoma in the body. A high LDH signals a heavier disease burden and is factored into the stage.
The site of spread matters for planning — brain metastases, for example, are watched and treated closely — but it no longer defines the outcome the way it once did. Modern systemic therapy works across all of these sites.
Clinical trials and drug approvals for advanced melanoma are often written for "unresectable stage III or stage IV" disease. A few plain-language definitions help:
Whether a melanoma is resectable is not always a permanent verdict. Tumors sometimes shrink enough on medication that an operation that was off the table becomes possible.
A stage II melanoma can be thick — more than 4 mm deep — and ulcerated, and it still is not "advanced." That is because stage II melanoma, however high-risk it looks under the microscope, has not been shown to spread anywhere: the lymph nodes are clear and imaging shows no distant disease. It is still treated with surgery as the main step, sometimes with a sentinel node biopsy and a conversation about adjuvant therapy for the highest-risk cases.
The line into "advanced" is crossed by evidence of spread — a positive node, an in-transit deposit, or a distant metastasis — not by the size or depth of the original tumor alone. A thick primary raises the risk that spread will be found, which is exactly why thicker melanomas are worked up more thoroughly.
Once melanoma has spread, removing what can be seen is no longer enough on its own, because cells may have traveled elsewhere. That is why the "advanced" label shifts the focus to medication that circulates through the whole body, coordinated by a team rather than a single surgeon.
It is also worth holding on to some perspective: advanced melanoma is far more treatable than it was a decade ago. Immunotherapy and targeted therapy have turned stage IV melanoma from a disease once measured in months into one where many people live for years, and some show no evidence of disease long after treatment.
"Advanced" melanoma is a category, not a verdict. It means one of two things: melanoma that has reached the regional lymph nodes or the skin around the primary tumor (stage III), or melanoma that has spread to distant sites such as the lung, liver, or brain (stage IV). The smaller labels — microscopic versus clinically detected nodes, the M1a–M1d categories, LDH level, resectable versus unresectable — all help the team match the treatment to the situation.
The common thread is that treatment moves from a single operation toward medication that works throughout the body, chosen and monitored by a team that treats melanoma regularly. That shift is also the reason outcomes have improved so much: the tools available for advanced melanoma today are far better than they were even a few years ago.
Disclaimer: This article is for educational purposes only and not a substitute for professional medical advice. Always consult a qualified dermatologist or oncologist about your personal diagnosis and treatment plan.
Chat with our AI guide for information about advanced melanoma
Chat with the Navigator